Firstminute capital and other investors have provided EUR 10 million in Series A funding to Munich-based HealthTech company Vantis to enhance chronic disease management through innovative digital solutions.

Information on the Target

Vantis, a Munich-based HealthTech company founded in 2019 by Till Jansen, Dr. Maximilian Rödel, and Dr. Kevin Wiesner, specializes in providing hybrid care for patients with chronic illnesses. The company integrates digital solutions such as telemedicine, data-driven remote monitoring, and artificial intelligence (AI) with regular doctor visits. Vantis operates a network of general medical practices to facilitate primary care and has developed digital therapy approaches, including the Vantis Cardiac and Heart Attack App, which is certified as a Digital Health Application (DiGA), along with the Vantis Hypertension App.

Industry Overview in Germany

The HealthTech industry in Germany has seen substantial growth, especially in light of the increasing demand for innovative healthcare solutions that address chronic diseases. This sector benefits from a robust regulatory framework that encourages the development and integration of digital health applications into standard medical practices. Furthermore, the COVID-19 pandemic has accelerated the adoption of telehealth services, reshaping the landscape of patient care and highlighting the necessity for technological advancements.

Germany's government has recognized the importance of digital transformation in healthcare, introducing various initiatives to promote telemedicine and digital health solutions. The Digital Healthcare Act, for instance, supports the r